Markets

Dexcel Israel

Dexcel Pharma is a leading manufacturer in the Israeli market, supplying approximately 1 out of 5 of all prescribed drugs in the country. Our portfolio includes Generics, OTC, Biosimilars, and innovative Rx drugs promoted under exclusive licensing agreements

Partnerships

We are proud to collaborate and build long-lasting partnerships with prominent biopharmaceutical companies

Broad Commercial Coverage in Israel

We have commercial expertise across primary-care and specialty-setting therapeutic areas including

oncology icon
Oncology
women's health icon
Women's Health
psychiatry
Psychiatry
dermatology icon
Dermatology
neurology icon
Neurology
endocinology icon
Endocrinology

Our capabilities

Business-oriented

Rapid execution of commercial agreements with an eye towards early market-access and commercial execution

Professional Marketing

Ability to lead new drug launch process from pre-commercial activities, KOL acceptance, market adoption and post-launch and product support

Efficient Registration

Our Experienced regulatory team allows us to file and register a range of pharmaceutical products, in alignment with local regulations

Full Market Coverage

We have complete coverage of healthcare professionals, covering all pharmacies across the country

Commercial and
Access Strength

We secure our market advantage and market penetration abilities with a proven track record and collaboration with Israeli health authorities, Health Funds, hospitals, and healthcare professionals

Brand Building

We have expertise in creating leading pharma brands while developing product positioning for a specific target audience